Tags

Type your tag names separated by a space and hit enter

Sacral Neuromodulation is Preferred over OnabotulinumtoxinA Injection for Overactive Bladder in Women: Con.
J Urol. 2017 09; 198(3):500-501.JU

Authors+Show Affiliations

University of Chicago Medicine, Chicago, Illinois.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

28751016

Citation

Bales, Gregory T.. "Sacral Neuromodulation Is Preferred Over OnabotulinumtoxinA Injection for Overactive Bladder in Women: Con." The Journal of Urology, vol. 198, no. 3, 2017, pp. 500-501.
Bales GT. Sacral Neuromodulation is Preferred over OnabotulinumtoxinA Injection for Overactive Bladder in Women: Con. J Urol. 2017;198(3):500-501.
Bales, G. T. (2017). Sacral Neuromodulation is Preferred over OnabotulinumtoxinA Injection for Overactive Bladder in Women: Con. The Journal of Urology, 198(3), 500-501. https://doi.org/10.1016/j.juro.2017.06.070
Bales GT. Sacral Neuromodulation Is Preferred Over OnabotulinumtoxinA Injection for Overactive Bladder in Women: Con. J Urol. 2017;198(3):500-501. PubMed PMID: 28751016.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Sacral Neuromodulation is Preferred over OnabotulinumtoxinA Injection for Overactive Bladder in Women: Con. A1 - Bales,Gregory T, Y1 - 2017/07/24/ PY - 2017/06/13/accepted PY - 2017/7/29/pubmed PY - 2019/3/22/medline PY - 2017/7/29/entrez SP - 500 EP - 501 JF - The Journal of urology JO - J Urol VL - 198 IS - 3 SN - 1527-3792 UR - https://www.unboundmedicine.com/medline/citation/28751016/Sacral_Neuromodulation_is_Preferred_over_OnabotulinumtoxinA_Injection_for_Overactive_Bladder_in_Women:_Con_ L2 - https://www.jurology.com/doi/10.1016/j.juro.2017.06.070?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub=pubmed DB - PRIME DP - Unbound Medicine ER -